GLP-1 (SM) – 20mg
B's Research Labs | Research Overview
B's Research Labs GLP-1 (SM), identified as GLP-1(SM) is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist designed to interact with GLP-1 receptors. Its molecular structure incorporates an aminoisobutyric acid (Aib) substitution and a C18 fatty diacid side chain attached through a specialized linker. These modifications influence peptide stability and receptor-mediated activity in experimental research models. Supplied in a 20 mg lyophilized powder format, GLP-1 (SM) is intended exclusively for controlled laboratory research and analytical applications. Laboratory investigations may focus on molecular structure, peptide stability, GLP-1 receptor-binding characteristics, metabolic signaling pathways, biochemical interactions, and receptor-mediated cellular responses under controlled experimental conditions. These investigations do not establish the safety, efficacy, or suitability of this research product for clinical applications.
RUO — RESEARCH USE ONLY
For in vitro laboratory research and analytical applications only.
NOT FOR HUMAN OR VETERINARY USE. NOT FOR CONSUMPTION, INJECTION, INGESTION, OR CLINICAL ADMINISTRATION.
Not intended for diagnostic, therapeutic, pharmaceutical, cosmetic, or personal use. No claims are made regarding safety, efficacy, or suitability for human or animal applications.
Compound Identification
GLP-1 (SM) is B's Research Labs' product designation for semaglutide, a synthetic GLP-1 receptor agonist investigated in molecular and biochemical research.
